<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03213210</url>
  </required_header>
  <id_info>
    <org_study_id>CLP-2017-02-18-1</org_study_id>
    <nct_id>NCT03213210</nct_id>
  </id_info>
  <brief_title>Efficacy of Synthetic Bone Graft for Treatment of Peri-implantitis</brief_title>
  <official_title>Clinical Efficacy of Easy-graft CLASSIC for the Treatment of Peri-implantitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunstar Americas</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunstar Americas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single arm study to evaluate the effectiveness of treatment approach using a new moldable&#xD;
      beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in&#xD;
      peri-implantitis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient recruitment&#xD;
  </why_stopped>
  <start_date type="Actual">November 12, 2018</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Probing Depth</measure>
    <time_frame>Change from baseline at 12 months after the surgery</time_frame>
    <description>Distance of probe penetration from gingival margin to bottom of peri-implant pocket</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Esthetic Satisfaction</measure>
    <time_frame>At 12 months after the surgery</time_frame>
    <description>To be assessed by examiner and subject using the Visual Analog Scales</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Marginal Bone Level</measure>
    <time_frame>Change from baseline at 6 and 12 months after the surgery</time_frame>
    <description>Change of marginal bone level on periapical standardized radiographs from baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Width of Keratinized Tissue</measure>
    <time_frame>Change from baseline at 6 and 12 months after the surgery</time_frame>
    <description>Distance between free gingival margin and mucogingival junction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical Attachment Level</measure>
    <time_frame>Change from baseline to at 6 and 12 months after the surgery</time_frame>
    <description>Distance of probe penetration from fixed reference to bottom of peri-implant</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Peri-Implantitis</condition>
  <arm_group>
    <arm_group_label>Device treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>easy-graft CLASSIC (beta-Tricalcium Phosphate)</intervention_name>
    <description>easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
    <arm_group_label>Device treatment</arm_group_label>
    <other_name>GUIDOR Bioresorbable Matrix Barrier</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject has read and signed the Institutional Review Board approved consent form&#xD;
             before treatment.&#xD;
&#xD;
          -  Subject must be age 21 or above.&#xD;
&#xD;
          -  Subject must be willing and able to follow study procedures and instructions.&#xD;
&#xD;
          -  Subject affected by moderate to severe peri-implant disease.&#xD;
&#xD;
          -  Treated chronic periodontitis and proper periodontal maintenance care.&#xD;
&#xD;
          -  Dental implant must meet the following criteria to be selected for the study:&#xD;
&#xD;
               1. Implant presenting Probing Depth ≥ 6 mm&#xD;
&#xD;
               2. Radiographic implant bone loss more than 25% of the implant length (Apex of the&#xD;
                  implant to implant platform) .&#xD;
&#xD;
               3. Peri implant bone defect being a buccal dehiscence and semicircular bone&#xD;
                  resorption to the middle of the implant body, buccal dehiscence and circular bone&#xD;
                  resorption with lingual bone plate intact or circular bone resorption with buccal&#xD;
                  and lingual bone plates intact&#xD;
&#xD;
               4. Single tooth implant restoration or implant supported fixed partial denture.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects participating (currently or within 30 days prior to enrollment) in other&#xD;
             clinical trials involving therapeutic intervention (either medical or dental).&#xD;
&#xD;
          -  Subjects with poor oral hygiene as indicated by a score of greater than 50% on the&#xD;
             O'Leary Plaque Index.&#xD;
&#xD;
          -  Subjects with a systemic condition, which would preclude periodontal treatment,&#xD;
             including but not limited to uncontrolled diabetes.&#xD;
&#xD;
          -  Subjects with acute infectious lesions in the areas intended for treatment.&#xD;
&#xD;
          -  Subjects taking chronic (i.e., &gt; 2 weeks), therapeutic doses of medications known to&#xD;
             affect bone metabolism such as nonsteroidal anti-inflammatory drugs or&#xD;
             bisphosphonates. Prophylactic aspirin (≤ 325 mg q.d.) for cardiovascular indications&#xD;
             will be permitted in subjects.&#xD;
&#xD;
          -  Female subjects who are pregnant or lactating, or sexually-active female subjects who&#xD;
             are of childbearing potential and are not using hormonal or barrier methods of birth&#xD;
             control. (except for when a result of pregnancy test is negative)&#xD;
&#xD;
          -  Subjects who are on any chronic antibiotic or steroidal therapy.&#xD;
&#xD;
          -  Smoker using more than 10 cigarettes or equivalent per day.&#xD;
&#xD;
          -  Smoker using cigar, smokeless tobacco use or e-cigarette.&#xD;
&#xD;
          -  Subjects diagnosed with drug induced gingival hyperplasia (e.g. calcium channel&#xD;
             blockers).&#xD;
&#xD;
          -  Subjects with radiographic evidence of pathology in other areas of the mouth besides&#xD;
             implant area to be treated.&#xD;
&#xD;
          -  Implant mobility.&#xD;
&#xD;
          -  Subjects with parafunctional habits and not wearing bite guard.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Creighton University School of Dentisty</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68178</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>July 7, 2017</study_first_submitted>
  <study_first_submitted_qc>July 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <results_first_submitted>February 4, 2021</results_first_submitted>
  <results_first_submitted_qc>February 4, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 23, 2021</results_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/10/NCT03213210/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Device Treatment</title>
          <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane&#xD;
easy-graft CLASSIC (beta-Tricalcium Phosphate): easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>6-month Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study termination</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Device Treatment</title>
          <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane&#xD;
easy-graft CLASSIC (beta-Tricalcium Phosphate): easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.6" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Probing Depth</title>
        <description>Distance of probe penetration from gingival margin to bottom of peri-implant pocket</description>
        <time_frame>Change from baseline at 12 months after the surgery</time_frame>
        <population>No subjects were examined at 12 months after the surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Device Treatment</title>
            <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane&#xD;
easy-graft CLASSIC (beta-Tricalcium Phosphate): easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Probing Depth</title>
          <description>Distance of probe penetration from gingival margin to bottom of peri-implant pocket</description>
          <population>No subjects were examined at 12 months after the surgery.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Esthetic Satisfaction</title>
        <description>To be assessed by examiner and subject using the Visual Analog Scales</description>
        <time_frame>At 12 months after the surgery</time_frame>
        <population>No subjects were examined at 12 months after the surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Device Treatment</title>
            <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane&#xD;
easy-graft CLASSIC (beta-Tricalcium Phosphate): easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Esthetic Satisfaction</title>
          <description>To be assessed by examiner and subject using the Visual Analog Scales</description>
          <population>No subjects were examined at 12 months after the surgery.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Marginal Bone Level</title>
        <description>Change of marginal bone level on periapical standardized radiographs from baseline.</description>
        <time_frame>Change from baseline at 6 and 12 months after the surgery</time_frame>
        <population>Marginal bone level was examined in 3 subjects at 6-month follow-up. No subjects were examined at 12 months after the surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Device Treatment</title>
            <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane&#xD;
easy-graft CLASSIC (beta-Tricalcium Phosphate): easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Marginal Bone Level</title>
          <description>Change of marginal bone level on periapical standardized radiographs from baseline.</description>
          <population>Marginal bone level was examined in 3 subjects at 6-month follow-up. No subjects were examined at 12 months after the surgery.</population>
          <units>percentage of bone height change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Width of Keratinized Tissue</title>
        <description>Distance between free gingival margin and mucogingival junction</description>
        <time_frame>Change from baseline at 6 and 12 months after the surgery</time_frame>
        <population>No subjects were examined at 6 and 12 months after the surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Device Treatment</title>
            <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane&#xD;
easy-graft CLASSIC (beta-Tricalcium Phosphate): easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Width of Keratinized Tissue</title>
          <description>Distance between free gingival margin and mucogingival junction</description>
          <population>No subjects were examined at 6 and 12 months after the surgery.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Clinical Attachment Level</title>
        <description>Distance of probe penetration from fixed reference to bottom of peri-implant</description>
        <time_frame>Change from baseline to at 6 and 12 months after the surgery</time_frame>
        <population>No subjects were examined at 6 and 12 months after the surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Device Treatment</title>
            <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane&#xD;
easy-graft CLASSIC (beta-Tricalcium Phosphate): easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Clinical Attachment Level</title>
          <description>Distance of probe penetration from fixed reference to bottom of peri-implant</description>
          <population>No subjects were examined at 6 and 12 months after the surgery.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months after the surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Device Treatment</title>
          <description>easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane&#xD;
easy-graft CLASSIC (beta-Tricalcium Phosphate): easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Akane Takemura</name_or_title>
      <organization>Sunstar Americas, Inc.</organization>
      <phone>8477944276</phone>
      <email>akane.takemura@us.sunstar.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

